Free Cash Flow: A measure of financial performance calculated as operating cash flow minus capital expenditures. Calculated as: Cash Flow from Operations + Net Property, Plant & Equipment Exp (a negative number)
Mersana Therapeutics, Inc. (MRSN) had Free Cash Flow of $-51.53M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$3.06M |
|
$-24.30M |
|
-- |
|
$3.06M |
|
$27.57M |
|
$-24.52M |
|
$0.22M |
|
$-24.30M |
|
$-24.30M |
|
$-24.30M |
|
$-24.30M |
|
$-24.30M |
|
$-24.30M |
|
$-24.52M |
|
$-24.23M |
|
4.99M |
|
4.99M |
|
$-4.87 |
|
$-4.87 |
|
| Balance Sheet Financials | |
$80.14M |
|
$1.04M |
|
$4.43M |
|
$84.57M |
|
$59.34M |
|
-- |
|
$78.38M |
|
$137.72M |
|
$-53.15M |
|
$-53.15M |
|
$-53.15M |
|
4.99M |
|
| Cash Flow Statement Financials | |
$-51.93M |
|
$27.39M |
|
$-6.25M |
|
$108.23M |
|
$77.45M |
|
$-30.78M |
|
$4.76M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.35 |
|
-- |
|
-- |
|
-- |
|
-0.33 |
|
100.00% |
|
-802.26% |
|
-802.26% |
|
-- |
|
-795.03% |
|
-795.03% |
|
|
Free Cash Flow |
$-51.53M |
-- |
|
-- |
|
-- |
|
0.04 |
|
-- |
|
11.49 |
|
7.83 |
|
45.72% |
|
45.72% |
|
-28.73% |
|
45.72% |
|
$-10.65 |
|
$-10.33 |
|
$-10.41 |
|